Independent coverage of AI, startups, and technology.
Topic
Hoffman: 2 recent articles from 1 sources, related entities, and follow-up coverage in one page.
Articles
2
Sources
1
Last update
Jun 5, 2026 at 22:35
Stay on the signal
Get a low-noise digest when this topic, source, or entity meaningfully moves.
After a very profitable decade on Microsoft's board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Reid Hoffman says tracking AI token use can gauge adoption, but cautions it should be paired with context and not treated as a direct productivity metric.
Signal weather
The story has moved beyond the first headline and now acts as a reliable context anchor.
Why now
This story is still moving and pulling follow-up coverage.
Ad slot
A reserved partner slot for relevant products, services, and editorial sponsorships.